The new drugs advent: clinical or economic outcomes?

Ann Oncol. 2006 Mar:17 Suppl 2:ii88-90. doi: 10.1093/annonc/mdj934.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / economics*
  • Antineoplastic Agents / therapeutic use
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / economics
  • Carcinoma, Non-Small-Cell Lung / mortality
  • Cost-Benefit Analysis
  • Economics, Pharmaceutical
  • Humans
  • Lung Neoplasms / drug therapy*
  • Lung Neoplasms / economics
  • Lung Neoplasms / mortality
  • Medical Oncology
  • Survival Analysis

Substances

  • Antineoplastic Agents